Aurora Cannabis Inc ACB

NAS: ACB | ISIN: CA05156X8843   14/11/2024
4,340 USD (-4,41%)
(-4,41%)   14/11/2024

9 september 2024 · Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge · Persbericht

12 augustus 2024 · Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting · Persbericht

7 augustus 2024 · Aurora Cannabis Announces Fiscal 2025 First Quarter Results and Delivers Positive Free Cash Flow · Persbericht

1 augustus 2024 · Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial collaboration · Persbericht

30 juli 2024 · Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2024 Annual General and Special Meeting of Shareholders · Persbericht

29 juli 2024 · Aurora Cannabis to Host First Quarter 2025 Investor Conference Call · Persbericht

26 juli 2024 · Aurora Receives Expanded Cultivation and Unique Research Licenses for German Facility · Persbericht

25 juli 2024 · Aurora Receives Expanded Cultivation and Unique Research Licenses for German Facility · Persbericht

9 juli 2024 · Aurora Cannabis Inc. Announces Filing and Mailing of Management Information Circular in Connection with Upcoming Annual General and Special Meeting of Shareholders · Persbericht

20 juni 2024 · Aurora Cannabis Files Full Year Results and Announces Fiscal 2024 Fourth Quarter · Persbericht

7 juni 2024 · Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2024 Investor Conference Call and File Related Year End Information · Persbericht

5 juni 2024 · Aurora Unveils Premium Resin Cartridges in Australia · Persbericht

15 mei 2024 · Aurora Cannabis Announces Appointment of New Director · Persbericht

8 mei 2024 · Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market · Persbericht

30 april 2024 · Aurora Improves Offerings in Australia with New Range of Premium Dried Flower Products · Persbericht

1 april 2024 · Aurora Cannabis Commends Germany's Landmark Legalization Achievement · Persbericht

20 maart 2024 · Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance · Persbericht

4 maart 2024 · Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia · Persbericht

29 februari 2024 · Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1] · Persbericht

28 februari 2024 · Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis · Persbericht

Mijn selecties